Czech
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
QJM - Monthly Journal of the Association of Physicians 2019-Nov

Nonalcoholic fatty liver disease as a risk factor for Clostridium Difficille-associated diarrhea.

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
Odkaz je uložen do schránky
W Nseir
S Hussein
R Farah
M Mahamid
H Khatib
J Mograbi
A Peretz
A Amara

Klíčová slova

Abstraktní

Clostridium difficile is the most common cause of infectious nosocomial diarrhea among adults in developed countries. Nonalcoholic fatty liver disease (NAFLD) is considered the most common chronic liver disease. Our goal was to assess whether there is any association between Clostridium difficile- associated diarrhea (CDAD) and NAFLD.We conducted a retrospective study of patients admitted with CDAD at Baruch Padeh Medical Center, Poria, Israel. Data on demographic characteristics, clinical signs, underlying conditions, presence of fatty liver based on CT/US imaging, and several risk factors for CDI were collected. The control group included patients with diarrhea who were negative for CDT and had been hospitalized during the same period. The controls were matched for age (± 5 years) , and gender.115/164 patients with CDAD met the inclusion criteria.The control group was consisted of 115 hospitalized patients with non-CDAD. The mean age of all the participants (230) was 69.57± 18 years. NAFLD was found in 76/115 (66%) patients with CDAD vs. 35/115 (30.4%) in the control group, P<0.001. Moreover, we found significant associations between CDAD group and metabolic syndrome, prior use of antibiotic in the last 3 months, NAFLD and high serum levels of C-reactive protein. Multivariate analysis showed that NAFLD, odds ratio (OR) 1.51, 95% confidence interval (CI): 1.2-1.95, P=0.05 was significantly associated with CDAD.This retrospective study showed that NAFLD is associated with the risk of CDAD. Moreover, metabolic syndrome and high serum levels of CRP were significantly associated with the risk of CDAD.

Připojte se k naší
facebookové stránce

Nejúplnější databáze léčivých bylin podložená vědou

  • Funguje v 55 jazycích
  • Bylinné léky podporované vědou
  • Rozpoznávání bylin podle obrázku
  • Interaktivní mapa GPS - označte byliny na místě (již brzy)
  • Přečtěte si vědecké publikace související s vaším hledáním
  • Hledejte léčivé byliny podle jejich účinků
  • Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty

Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu

Google Play badgeApp Store badge